Crafting Life-Changing Success in the Pharmaceuticals Market
Are you set to escalate your biologic drugs business beyond existing territories? Navigate global with Taevas’ global reach, expertise and network.
Growth Drivers
- Rise in Autoimmune Diseases: The increasing prevalence of autoimmune diseases globally stimulates the demand for biologics.
- Biosimilars Approval: The increased approval of biosimilars, especially in regulated markets, drives the expansion of the market.
- Advanced Drug Delivery Methods: Innovations in drug delivery methods for biologics, like smart patches and inhalable biologics, spur market growth.
$479.7 billion
By 2027
8.5%
CAGR
North America
Dominant region